Human regulatory B cells control the TFH cell response
- PMID: 27865860
- DOI: 10.1016/j.jaci.2016.09.042
Human regulatory B cells control the TFH cell response
Abstract
Background: Follicular helper T (TFH) cells support terminal B-cell differentiation. Human regulatory B (Breg) cells modulate cellular responses, but their control of TFH cell-dependent humoral immune responses is unknown.
Objective: We sought to assess the role of Breg cells on TFH cell development and function.
Methods: Human T cells were polyclonally stimulated in the presence of IL-12 and IL-21 to generate TFH cells. They were cocultured with B cells to induce their terminal differentiation. Breg cells were included in these cultures, and their effects were evaluated by using flow cytometry and ELISA.
Results: B-cell lymphoma 6, IL-21, inducible costimulator, CXCR5, and programmed cell death protein 1 (PD-1) expressions increased on stimulated human T cells, characterizing TFH cell maturation. In cocultures they differentiated B cells into CD138+ plasma and IgD-CD27+ memory cells and triggered immunoglobulin secretions. Breg cells obtained by Toll-like receptor 9 and CD40 activation of B cells prevented TFH cell development. Added to TFH cell and B-cell cocultures, they inhibited B-cell differentiation, impeded immunoglobulin secretions, and expanded Foxp3+CXCR5+PD-1+ follicular regulatory T cells. Breg cells modulated IL-21 receptor expressions on TFH cells and B cells, and their suppressive activities involved CD40, CD80, CD86, and intercellular adhesion molecule interactions and required production of IL-10 and TGF-β.
Conclusion: Human Breg cells control TFH cell maturation, expand follicular regulatory T cells, and inhibit the TFH cell-mediated antibody secretion. These novel observations demonstrate a role for the Breg cell in germinal center reactions and suggest that deficient activities might impair the TFH cell-dependent control of humoral immunity and might lead to the development of aberrant autoimmune responses.
Keywords: IL-12; IL-21; Regulatory B cells; antibody production; follicular T helper cells; humoral immune response.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis.Respir Res. 2019 Nov 6;20(1):244. doi: 10.1186/s12931-019-1216-6. Respir Res. 2019. PMID: 31694639 Free PMC article.
-
IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren's syndrome.Cell Mol Immunol. 2019 Dec;16(12):921-931. doi: 10.1038/s41423-019-0227-z. Epub 2019 Apr 4. Cell Mol Immunol. 2019. PMID: 30948793 Free PMC article.
-
The Regulation between CD4+CXCR5+ Follicular Helper T (Tfh) Cells and CD19+CD24hiCD38hi Regulatory B (Breg) Cells in Gastric Cancer.J Immunol Res. 2022 Oct 26;2022:9003902. doi: 10.1155/2022/9003902. eCollection 2022. J Immunol Res. 2022. PMID: 36339942 Free PMC article.
-
Development of T follicular helper cells and their role in disease and immune system.Biomed Pharmacother. 2016 Dec;84:1668-1678. doi: 10.1016/j.biopha.2016.10.083. Epub 2016 Nov 15. Biomed Pharmacother. 2016. PMID: 27863842 Review.
-
Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses.Front Immunol. 2018 Oct 22;9:2412. doi: 10.3389/fimmu.2018.02412. eCollection 2018. Front Immunol. 2018. PMID: 30405612 Free PMC article. Review.
Cited by
-
The response of CD27+CD38+ plasmablasts, CD24hiCD38hi transitional B cells, CXCR5-ICOS+PD-1+ Tph, Tph2 and Tfh2 subtypes to allergens in children with allergic asthma.BMC Pediatr. 2024 Feb 29;24(1):154. doi: 10.1186/s12887-024-04622-4. BMC Pediatr. 2024. PMID: 38424520 Free PMC article.
-
Circulating T follicular helper 2 cells, T follicular regulatory cells and regulatory B cells are effective biomarkers for predicting the response to house dust mite sublingual immunotherapy in patients with allergic respiratory diseases.Front Immunol. 2023 Nov 24;14:1284205. doi: 10.3389/fimmu.2023.1284205. eCollection 2023. Front Immunol. 2023. PMID: 38111589 Free PMC article.
-
Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus.Front Immunol. 2023 Sep 12;14:1230264. doi: 10.3389/fimmu.2023.1230264. eCollection 2023. Front Immunol. 2023. PMID: 37771588 Free PMC article. Review.
-
Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?Life (Basel). 2023 Sep 18;13(9):1931. doi: 10.3390/life13091931. Life (Basel). 2023. PMID: 37763334 Free PMC article. Review.
-
Tolerogenic dendritic cells in type 1 diabetes: no longer a concept.Front Immunol. 2023 Jun 14;14:1212641. doi: 10.3389/fimmu.2023.1212641. eCollection 2023. Front Immunol. 2023. PMID: 37388741 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
